Gratis Versand ab 14,99 €. Mehr Infos.
Bookbot

Alzheimer Disease

Neuropsychology and Pharmacology

Autor*innen

Parameter

  • 316 Seiten
  • 12 Lesestunden

Mehr zum Buch

Alzheimer disease (AD) has become the most common form of dementia in industrialized countries and represents an increasing burden at the economic, social and medical level. In discussing both the biological aspects of AD as well as the cognitive functions involved, Alzheimer Disease - Neuropsychology and Pharmacology presents a comprehensive picture of the pathology and approaches to diagnosis and treatment. Basic research including animal models, molecular and genetic aspects is also taken into consideration. In part I, the biological correlates of AD are discussed. In part II the neuropsychological aspects such as cognitive impairment, loss of functional autonomy and emergence of neuropsychiatric disturbances of AD are outlined. In part III, strategies for effective treatment and prevention of AD are discussed. This book will be a useful source of information for clinicians as well as researchers in the area of neuropharmacology.

Publikation

Buchkauf

Alzheimer Disease, Ge rard Emilien

Sprache
Erscheinungsdatum
2012
product-detail.submit-box.info.binding
(Paperback)
Wir benachrichtigen dich per E-Mail.

Lieferung

  • Gratis Versand ab 14,99 € in ganz Deutschland! Mehr Infos.

Zahlungsmethoden

Keiner hat bisher bewertet.Abgeben

Titel
Alzheimer Disease
Untertitel
Neuropsychology and Pharmacology
Sprache
Englisch
Autor*innen
Ge rard Emilien
Erscheinungsdatum
2012
Einband
Paperback
Seitenzahl
316
ISBN10
3034895917
ISBN13
9783034895910
Reihe
Beschreibung
Alzheimer disease (AD) has become the most common form of dementia in industrialized countries and represents an increasing burden at the economic, social and medical level. In discussing both the biological aspects of AD as well as the cognitive functions involved, Alzheimer Disease - Neuropsychology and Pharmacology presents a comprehensive picture of the pathology and approaches to diagnosis and treatment. Basic research including animal models, molecular and genetic aspects is also taken into consideration. In part I, the biological correlates of AD are discussed. In part II the neuropsychological aspects such as cognitive impairment, loss of functional autonomy and emergence of neuropsychiatric disturbances of AD are outlined. In part III, strategies for effective treatment and prevention of AD are discussed. This book will be a useful source of information for clinicians as well as researchers in the area of neuropharmacology.